The effectiveness of ACE-Inhibitor for preventing pneumonia; Systematic review and meta-analysis
Not Applicable
Not yet recruiting
- Conditions
- Pneumonia
- Registration Number
- JPRN-UMIN000039424
- Lead Sponsor
- Shiga University of Medical Science Hospital, Department of family medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 0
Inclusion Criteria
Not provided
Exclusion Criteria
Nothing
Study & Design
- Study Type
- Others,meta-analysis etc
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Incidence of pneumonia(Duration: the longest follow-up of each primary study), Definition: the presence of new pneumonic changes in the chest x-ray and clinical signs of pneumonia; cough, fever, sputum production and pleuritic chest pain. we will also accept pneumonia as the original authors defined)
- Secondary Outcome Measures
Name Time Method Mortality(Duration: the longest follow-up of each primary study) Withdrawal due to adverse effects(Duration: the longest follow-up of each primary study) Swallowing function(Duration: the longest follow-up of each primary study, Definition:Assessed by the Royal Brisbane Hospital Outcome Measure for Swallowing(RBHOMS) score, the dysphagia severity rating scale (DSRS), the functional oral intake scale (FOIS), the dysphagia outcome and severity scale (DOSS), or water swallowing tests)